Trnka L[au] - Search Results

Year	Number of Results
1954	1
1961	2
1962	1
1963	5
1964	4
1965	3
1966	5
1967	4
1968	4
1969	3
1970	1
1971	2
1973	1
1974	3
1975	1
1976	1
1977	1
1978	1
1979	9
1980	6
1981	2
1982	2
1983	1
1984	2
1985	2
1986	1
1987	1
1988	1
1989	4
1990	4
1991	1
1992	1
1993	5
1994	2
1995	2
1996	1
1998	1
1999	3
2000	2
2001	3
2002	2
2003	1
2007	2
2008	1
2017	1
2022	0

1

Limitations in the description of conformational preferences of C-disaccharides: The (1 → 3)-C-mannobiose case.

Raich I, Lövyová Z, Trnka L, Parkan K, Kessler J, Pohl R, Kaminský J. Raich I, et al. Among authors: trnka l. Carbohydr Res. 2017 Nov 8;451:42-50. doi: 10.1016/j.carres.2017.09.006. Epub 2017 Sep 18. Carbohydr Res. 2017. PMID: 28950209

2

[PRIMARY RESISTANCE OF M. TUBERCULOSIS AGAINST ANTITUBERCULAR AGENTS].

TRNKA L, URBANCIK R. TRNKA L, et al. Cas Lek Cesk. 1963 Jul 12;102:793-801. Cas Lek Cesk. 1963. PMID: 14074220 Review. Czech. No abstract available.

3

Resolution and identification of ribosomes from mycobacteria.

Trnka L, Wiegeshaus E, Smith DW. Trnka L, et al. J Bacteriol. 1968 Feb;95(2):310-3. doi: 10.1128/jb.95.2.310-313.1968. J Bacteriol. 1968. PMID: 4867735 Free PMC article.

4

[Remarks on the theory of Mycobacterium tuberculosis resistance to antitubercular agents].

Urbancík R, Trnka L. Urbancík R, et al. Among authors: trnka l. Lek Veda Zahr. 1966 Mar 11;3:53-61. Lek Veda Zahr. 1966. PMID: 4956168 Review. Czech. No abstract available.

5

Comparison of tuberculosis surveillance systems in low-incidence industrialised countries.

Mor Z, Migliori GB, Althomsons SP, Loddenkemper R, Trnka L, Iademarco MF. Mor Z, et al. Among authors: trnka l. Eur Respir J. 2008 Dec;32(6):1616-24. doi: 10.1183/09031936.00042908. Epub 2008 Aug 6. Eur Respir J. 2008. PMID: 18684850 Free article.

6

Estrogen-induced cholestasis results in a dramatic increase of b-series gangliosides in the rat liver.

Majer F, Trnka L, Vítek L, Jirkovská M, Marecek Z, Smíd F. Majer F, et al. Among authors: trnka l. Biomed Chromatogr. 2007 May;21(5):446-50. doi: 10.1002/bmc.743. Biomed Chromatogr. 2007. PMID: 17357127

7

A cost-benefit analysis of BCG revaccination in the Czech Republic.

Pathania VS, Trnka L, Krejbich F, Dye C. Pathania VS, et al. Among authors: trnka l. Vaccine. 1999 Apr 9;17(15-16):1926-35. doi: 10.1016/s0264-410x(98)00462-9. Vaccine. 1999. PMID: 10217591

8

The phenotype of alveolar macrophages and its correlation with immune cells in bronchoalveolar lavage.

Stríz I, Wang YM, Svarcová I, Trnka L, Sorg C, Costabel U. Stríz I, et al. Among authors: trnka l. Eur Respir J. 1993 Oct;6(9):1287-94. Eur Respir J. 1993. PMID: 7904572

9

Six years' experience with the discontinuation of BCG vaccination. 2. Cost and benefit of mass BCG vaccination.

Trnka L, Danková D, Svandová E. Trnka L, et al. Tuber Lung Dis. 1993 Aug;74(4):288-92. doi: 10.1016/0962-8479(93)90056-4. Tuber Lung Dis. 1993. PMID: 8219182

10

Comparison of the antituberculous activity of morphazinamide and pyrazinamide on chronic experimental tuberculosis. II. The emergence of resistance and its retardation in the course of monotherapy and combinations of antituberculous drugs.

Havel A, Trnka L, Kuska J. Havel A, et al. Among authors: trnka l. Chemotherapia (Basel). 1964-1965;9(3):168-75. doi: 10.1159/000220357. Chemotherapia (Basel). 1964. PMID: 4953658 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results